This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hodgson, T.A. Articles by Greenspan, J.S. Search for Related Content PubMed PubMed Citation Articles by Hodgson, T.A. Articles by Greenspan, J.S. Pubmed/NCBI databases Medline Plus Health Information AIDS Medicines Mouth Disorders Oral Cancer Social Bookmarking                         What's this?

Oral Lesions of HIV Disease and HAART in Industrialized Countries

T.A. Hodgson^1,*, D. Greenspan² and J.S. Greenspan²

¹ Unit of Oral Medicine, UCL Eastman Dental Institute and UCLHT Eastman Dental Hospital, 256 Gray’s Inn Road, London, WC1X 8LD, UK; and
² Department of Orofacial Sciences and the Oral AIDS Center, School of Dentistry, The University of California, San Francisco, CA 94143-0422, USA

Correspondence: ^* corresponding author, t.hodgson{at}eastman.ucl.ac.uk

The epidemiology of HIV-related oral disease in industrialized nations has evolved following the initial manifestations described in 1982. Studies from both the Americas and Europe report a decreased frequency of HIV-related oral manifestations of 10–50% following the introduction of HAART (highly active antiretroviral therapy). Evidence suggests that HAART plays an important role in controlling the occurrence of oral candidosis. The effect of HAART on reducing the incidence of oral lesions, other than oral candidosis, does not appear as significant, possibly as a result of low lesion prevalence in industrialized countries. In contrast to other oral manifestations of HIV, an increased prevalence of oral warts in patients on HAART has been reported from the USA and the UK. HIV-related salivary gland disease may show a trend of rising prevalence in the USA and Europe. The re-emergence of HIV-related oral disease may be indicative of failing therapy. A range of orofacial iatrogenic consequences of HAART has been reported, and it is often difficult to distinguish between true HIV-related oral disease manifestations and the adverse effects of HAART. A possible association between an increased risk of oral squamous cell carcinoma and HIV infection has been suggested by at least three epidemiological studies, with reference to the lip and tongue. These substantial and intensive research efforts directed toward enhancing knowledge regarding the orofacial consequences of HIV infection in the industrialized nations require dissemination in the wider health care environment.

Key Words: Oral • HIV • AIDS • HAART • industrialized

Advances in Dental Research, Vol. 19, No. 1, 57-62 (2006)
DOI: 10.1177/154407370601900112


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. L Ortega, A. Ceballos-Salobrena, L. A Gaitan-Cepeda, and M. G Magalhaes Oral manifestations after immune reconstitution in HIV patients on HAART Int J STD AIDS, May 1, 2008; 19(5): 305 - 308. [Abstract] [Full Text] [PDF]

				M. Umadevi, O. Adeyemi, M. Patel, P.A. Reichart, and P.G. Robinson (B2) Periodontal Diseases and Other Bacterial Infections Advances in Dental Research, April 1, 2006; 19(1): 139 - 145. [Abstract] [Full Text] [PDF]